Valuation : PolyPeptide Group AG

Market Cap 1.54B 1.8B 1.45B 1.33B 2.48B 170B 2.49B 17.22B 6.66B 86.98B 6.74B 6.6B 277B P/E 2026 *
49.2x
P/E 2027 * 29.6x
Enterprise Value 1.66B 1.93B 1.56B 1.42B 2.66B 182B 2.67B 18.47B 7.14B 93.29B 7.23B 7.08B 297B EV / Sales 2026 *
3.33x
EV / Sales 2027 * 2.95x
Free-Float
39.12%
Yield 2026 *
-
Yield 2027 * 0.14%
1 day+0.11%
1 week-0.11%
Current month-0.11%
1 month+0.11%
3 months+20.88%
6 months+85.26%
Current year+68.58%
1 week 43.95
Extreme 43.95
44.15
1 month 43.9
Extreme 43.9
44.15
Current year 23.1
Extreme 23.1
50.1
1 year 21.8
Extreme 21.8
50.1
3 years 13.22
Extreme 13.22
50.1
5 years 13.22
Extreme 13.22
146
10 years 13.22
Extreme 13.22
147.4
Manager TitleAgeSince
Chief Executive Officer 54 2023-04-11
Director of Finance/CFO 54 2024-01-01
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Director/Board Member 73 2005-12-31
Chairman 69 2021-03-31
Director/Board Member 62 2020-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
11/13/23 Buy 2,500 0.0075%
10/12/23 Buy 159,959 0.4829%
4/6/23 Buy 45,842 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
+0.11%-0.11%+69.23%+98.20% 1.79B
-0.88%-0.64%+58.05%+100.51% 1,024B
-1.15%+3.53%+54.25%+71.99% 663B
-1.44%+0.02%+20.65%+72.22% 453B
-0.95%+0.23%+28.96%+37.78% 352B
-3.18%+1.78%+20.66%+41.55% 304B
+0.30%+0.60%-0.40%+11.25% 252B
-1.55%+1.71%+54.15%+71.87% 236B
+0.02%+2.24%-14.59%-55.80% 206B
-0.15%+3.18%+31.24%+104.21% 187B
Average -0.89%+1.16%+32.22%+55.38% 368.02B
Weighted average by Cap. -1.07%+0.64%+37.22%+64.52%

Financials

2026 *2027 *
Net sales 498M 579M 468M 427M 799M 54.72B 802M 5.55B 2.14B 28.02B 2.17B 2.13B 89.25B 574M 667M 540M 493M 921M 63.08B 924M 6.4B 2.47B 32.31B 2.5B 2.45B 103B
Net income 25M 29.07M 23.51M 21.46M 40.14M 2.75B 40.27M 279M 108M 1.41B 109M 107M 4.48B 45M 52.33M 42.32M 38.64M 72.26M 4.95B 72.49M 502M 194M 2.53B 197M 192M 8.07B
Net Debt 112M 130M 105M 96.16M 180M 12.32B 180M 1.25B 483M 6.31B 489M 478M 20.09B 146M 170M 137M 125M 234M 16.06B 235M 1.63B 629M 8.22B 638M 624M 26.19B
Logo PolyPeptide Group AG
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Employees
1,460
Date Price Change Volume
26-09-07 CHF 44.00 +0.11% 25,276
26-09-04 CHF 43.95 0.00% 46,222
26-09-03 CHF 43.95 -0.23% 82,663
26-09-02 CHF 44.05 +0.11% 64,063
26-09-01 CHF 44.00 -0.11% 71,068
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
46.78EUR
Average target price
42.12EUR
Spread / Average Target
-9.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PPGN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!